Sp553
MANAGING FUNCTIONAL DYSPEPSIA IN THE OFFICE
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia.
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia.
Presenter
Dartmouth-Hitchcock Medical Center
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
A NOVEL, NON-INVASIVE, 6-DAY WIRELESS MOTILITY PATCH SYSTEM DEMONSTRATES UNIQUE MYOELECTRICAL PATTERNS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA, GASTROPARESIS, AND VOMITING.
INTRODUCTION: Patients with upper gastrointestinal (UGI) symptoms of abdominal pain, nausea, vomiting, and bloating often complain within the postprandial period…
PANEL DISCUSSION
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
